Nil Yakar

Nil Yakar

Auto-generated profile, based on publicly available information

Nil Yakar

The ADA Forsyth Institute Cambridge Massachusetts USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2024 in Journal of Oral Microbiology
Verified
Journal Article
Open access
NYNil Yakar
Nil Yakar
ÖÜÖzge Ünlü
Özge Ünlü
LCLujia Cen
Lujia Cen
HHHatice Hasturk
Hatice Hasturk
TCTsute Chen
Tsute Chen
AKAlpdogan Kantarci
Alpdogan Kantarci
Fusobacterium nucleatum, a pathobiont in periodontal disease, contributes to alveolar bone destruction. We assessed the efficacy of a new targeted antimicrobial, FP-100, in eradicating F. nucleatum from the oral microbial community in vitro and in vivo and evaluated its effectiveness in reducing bone loss in a mouse periodontitis model. A multispecies bacterial community was cultured and treated with two concentrations of FP-100 over two days. Microbial profiles were examined at 24-h intervals using 16S rRNA sequencing. A ligature-induced periodontitis mouse model was employed to test FP-100 in vivo. FP-100 significantly reduced Fusobacterium spp. within the in vitro community (p < 0.05) without altering microbial diversity at a 2 μM concentration. In mice, cultivable F. nucleatum was undetectable in FP-100-treated ligatures but persistent in controls. Beta diversity plots showed distinct microbial structures between treated and control mice. Alveolar bone loss was significantly reduced in the FP-100 group (p = 0.018), with concurrent decreases in gingival IL-1β and TNF-α expression (p = 0.052 and 0.018, respectively). FP-100 effectively eliminates F. nucleatum from oral microbiota and significantly reduces bone loss in a mouse periodontitis model, demonstrating its potential as a targeted therapeutic agent for periodontal disease.

14 July 2024 in Journal of Periodontology
Verified
Journal Article
Closed access
NYNil Yakar
Nil Yakar
BYBusra Yilmaz
Busra Yilmaz
GEGulnur Emingil
Gulnur Emingil
TCTsute Chen
Tsute Chen
GOGuven Ozdemir
Guven Ozdemir
AKAlpdogan Kantarci
Alpdogan Kantarci

18 October 2023 in Journal of Periodontology
Verified
Journal Article
Open access
NYNil Yakar
Nil Yakar
Nagihan BostanciNagihan Bostanci
Nagihan Bostanci
GÖGüven Özdemir
Güven Özdemir
HAHarika Atmaca
Harika Atmaca
ATAsena Türedi
Asena Türedi
GEGülnur Emingil
Gülnur Emingil
Background: The decline of estrogen levels during menopause impacts weight, mood, and overall health, both orally and systemically. This study assessed salivary levels of tumor necrosis factor alpha (TNF‐α), interleukin‐6 (IL‐6), IL‐10, and IL‐7 in postmenopausal (PMW) and regularly menstruating premenopausal (RMPW) women, while considering serum cytokine levels, body mass index (BMI), periodontal health, and self‐reported physical and emotional well‐being.Methods: In this study, 75 PMW and 71 RMPW were included. Clinical and periodontal parameters were evaluated, and perceived health was assessed with the Women's Health Questionnaire (WHQ). Cytokine levels in both saliva and serum were quantified by enzyme‐linked immunosorbent assay (ELISA). Covariate evaluations of salivary cytokines were conducted using hierarchical linear regression modeling.Results: Cytokines were detectable in saliva from 71 PMW and 67 RMPW. In the initial unadjusted model, IL‐7, IL‐10, and TNF‐α exibited significant differences between RMPW and PMW. However, these differences became non‐significant (p > 0.05) in the final model after adjusting for age, which implies a negligible effect of the investigated covariates on salivary cytokine levels when age was considered. Lower levels of IL‐6 in PMW, which initially showed no significant difference, became borderline (p = 0.054) in the final model after adjusting for age.Conclusions: After adjusting for multiple factors, no significant difference was found in the salivary levels of the investigated cytokines between RMPW and PMW. Factors such as BMI, perceived health, serum cytokine levels, and periodontal parameters seem to minimally influence these levels in PMW. However, age may be a stronger confounding factor.

2 August 2023 in Journal of Periodontal Research
Verified
Journal Article
Open access
NYNil Yakar
Nil Yakar
GEGulnur Emingil
Gulnur Emingil
ATAsena Türedi
Asena Türedi
ÇŞÇağdaş Şahin
Çağdaş Şahin
TKTimur Köse
Timur Köse
ASAngelika Silbereisen
Angelika Silbereisen
Objective: This study aimed to investigate the association of GCF TREM‐1, PGLYRP1, and IL‐1β levels with periodontal health in pre‐ and postmenopausal women.Background: Triggering receptor expressed on myeloid cells 1 (TREM‐1), activated through its ligand peptidoglycan recognition protein 1 (PGLYRP1), stimulates proinflammatory cytokine production, such as interleukin (IL)‐1β, during periodontal inflammation. Postmenopausal changes may modulate these immune‐inflammatory functions. No clinical study has yet investigated the effect of menopause on TREM‐1, PGLYRP1, and IL‐1β levels in gingival crevicular fluid (GCF).Methods: This cross‐sectional study included 148 women (age range = 35–65 years), divided into postmenopausal women (PMW) (n = 76, mean age = 54 ± 5 years) and regularly menstruating premenopausal women (RMPW) (n = 72, mean age = 40 ± 4 years). Clinical periodontal parameters were recorded. TREM‐1, PGLYRP1, and IL‐1β levels were quantified with enzyme‐linked immunosorbent assays. Pearson's Chi‐squared test and Mann–Whitney‐U test were used to compare categorical and numerical variables, respectively. Spearman's Rho correlation analysis was used to test the linear relationship between variables. Analyte level data were categorized based on the periodontal diagnosis and menopause status (2 × 2 nonparametric factorial ANOVA).Results: No significant differences in TREM‐1, PGLYRP1, and IL‐1β levels between PMW and RMPW were observed (p > .05). Mean values of periodontal indexes including probing depth did not differ significantly between PMW and RMPW groups (p = .474). TREM‐1 levels were significantly higher in both PMW and RMPW with periodontitis, compared to gingivitis or health (p = .0021).Conclusion: Menopause‐related changes have no observable effect on GCF levels of TREM‐1, PGLYRP1, and IL‐1β. Higher GCF TREM‐1 levels in women with periodontitis regardless of their menopausal status indicate that TREM‐1 may be an indicator for periodontitis both in premenopausal and postmenopausal women.

13 April 2026 in Journal of Periodontology
Verified
Journal Article
Open access
ÖÜÖzge Ünlü
Özge Ünlü
TCTsute Chen
Tsute Chen
NYNil Yakar
Nil Yakar
ZGZeliha Guney
Zeliha Guney
BPBruce J Paster
Bruce J Paster
AKAlpdogan Kantarci
Alpdogan Kantarci
Background: The microbiome is a dynamic system that changes throughout life. Studies have revealed the relationship between periodontal disease and the oral microbiota; however, the impact of periodontal disease on the expression of senescence markers and on the inflammaging of the oral and systemic microbiome remains unclear. We hypothesized that aging increases the periodontitis‐induced changes in the oral and systemic microbiome and is accompanied by an altered inflammatory response. Methods: Experimental periodontitis was induced in 18‐month‐old (old) and 8‐month‐old (young) C57BL/6 mice by placing ligatures around the second maxillary molars. Bone morphometric analyses were conducted to assess bone loss. Senescence‐ and inflammatory‐related gene expression in the gingiva was measured by quantitative polymerase chain reaction (qPCR). Serum inflammatory markers were evaluated via immunoassay. Oral, brain, and gut microbial content were analyzed using next‐generation sequencing. Results: Maxillary bone loss was significantly higher in the old mice with periodontal disease than in young mice. Senescence and inflammatory markers were higher in old mice than in young ones, and periodontitis increased their expression. The alpha diversity of the oral and brain microbial communities differed significantly between old and young mice. Treponema denticola , Fusobacterium nucleatum, Porphyromonas gingivalis, P. pasteri , and Prevotella nigrescens were only detected in the brains of old animals with periodontitis. Conclusion: Periodontopathogens and oral commensals are either only found in the brains of old animals with periodontal disease or are more prevalent in the brains of old animals, suggesting that aging and periodontitis may contribute to the dissemination of oral bacteria to the brain. Plain language summary: Aging may increase the periodontitis‐induced changes in the oral and systemic microbiome, which an altered inflammatory response may accompany. Experimental periodontitis was created in old and young mouse models. Bone loss, senescence, and inflammatory gene expression and serum inflammatory markers were assessed in each model, and oral, brain, and gut microbial content was analyzed. Senescence and inflammatory markers were higher in old mice than in young ones, and periodontitis increased their expression. Our results suggested that aging and periodontitis may contribute to the dissemination of oral bacteria to the brain.

17 December 2025 in Journal of Dental Research
Verified
Journal Article
Open access
EDEzgi Demir
Ezgi Demir
IİILGIN İLGENLİ
ILGIN İLGENLİ
ZGZeliha Guney
Zeliha Guney
SMS. Mohammadi
S. Mohammadi
KLK. Lauwens
K. Lauwens
AKAlpdogan Kantarci
Alpdogan Kantarci
Chronic apical periodontitis (CAP) is a persistent inflammatory condition caused by microbial infections in the root canal system, leading to bone loss and tissue damage. In this study, we tested the hypothesis that maresin 1 (MaR1), a specialized proresolving mediator, facilitates inflammatory resolution and promotes bone healing in CAP. We developed a CAP model in mice through pulp exposure. Animals received intracanal administration of either MaR1 or a vehicle. Micro–computed tomography (micro-CT) was used to analyze lesion size and bone volume changes. Inflammatory cell infiltration was assessed in hematoxylin and eosin–stained sections, and microbial diversity was analyzed using next-generation sequencing. The role of regulatory T cells (Tregs) was further explored through diphtheria toxin–induced depletion of Tregs in Foxp3eGFP/IL17 transgenic mice. All statistical analyses were performed using parametric methods, as confirmed by the Shapiro–Wilk test for data normality. Analysis of variance with Tukey’s post hoc and Bonferroni-corrected t tests was applied. P < 0.05 was considered significant. In 2-dimensional analyses, a significant difference was observed between the control and lesion groups, supporting the validity of the experimental model. MaR1 treatment significantly reduced lesion size ( P < 0.0001). The bone volume/total volume ratio was significantly higher in the MaR1 group than in the vehicle group ( P < 0.05). Bone mass was reduced in the lesion group, whereas MaR1 treatment significantly alleviated this loss ( P < 0.05). The number of inflammatory cells was significantly lower in the MaR1 group compared to the vehicle group ( P < 0.05). MaR1 also reduced Enterococcus faecalis , a key pathogen in persistent infections. This study highlights MaR1 as a promising treatment for chronic apical periodontitis, showing benefits in resolving inflammation, preserving bone, and reducing E. faecalis . Unlike conventional therapies, MaR1 supports immune modulation and tissue repair.